UnitedHealth stock slips again as Truist, JPMorgan trim targets and Medicare Advantage rates loom
UnitedHealth shares fell about 1.2% to $282.20 by midday Tuesday after Truist and JPMorgan cut their price targets to $370 and $389, respectively. Investors cited concerns over Medicare Advantage payment changes and rising medical costs. UnitedHealth recently projected 2026 revenue above $439 billion with adjusted earnings expected to top $17.75 per share.